Żywicka Bogusława, Struszczyk Marcin Henryk, Paluch Danuta, Kostanek Krzysztof, Krucińska Izabella, Kowalski Krzysztof, Kopias Kazimierz, Rybak Zbigniew, Szymonowicz Maria, Gutowska Agnieszka, Kubiak Paweł
Pre-clinical Research Center, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland.
Institute of Security Technologies "MORATEX", Curie-Sklodowskiej 3, 90-505 Lodz, Poland.
Materials (Basel). 2022 Apr 5;15(7):2671. doi: 10.3390/ma15072671.
A knitted implant, unilaterally modified with plasma-assisted chemical-vapor deposition (PACVD), and with a nano-layer of fluorine derivative supplementation, for reducing the risk of complications related to adhesions, and the formation of a thick postoperative scar was prepared. The biological evaluation of designed or modified medical devices is the main aspect of preclinical research. If such studies use a medical device with prolonged contact with connective tissue (more than 30 days), biocompatibility studies require a safety assessment in terms of toxicity in vitro and in vivo, allergenicity, irritation, and cancerogenicity, reproductive and developmental toxicity. The ultimate aspect of biological evaluation is biofunctionality, and evaluation of the local tissue response after implantation, resulting in the determination of all aspects of local biocompatibility with the implemented synthetic material. The implantation of PACVD-modified materials in muscle allows us to estimate the local irritation effect on the connective tissue, determining the risk of scar formation, whereas implantation of the above-mentioned knitted fabric into the abdominal wall, assists with evaluating the risk of fistula formation-the main post-surgical complications. The research aimed to evaluate the local reaction of the soft tissues after the implantation of the knitted implants modified with PACVD of the fluoropolymer in the nanostuctural form. The local effect that occurred during the implantation of the designed implants was quantitatively and qualitatively evaluated when PACVD unmodified (reference), and modified medical devices were implanted in the abdominal cavity (intra-abdominal position) for 12 or into the muscles for 56 weeks. The comparative semi-quantitative histological assessment included the severity of inflammatory cells (multinucleated cells, lymphocytes, plasma cells, macrophages, giant cells) and the tissue response (necrosis, neovascularization, fibrosis, and fat infiltration) on a five-point scale. The knitted implants modified by PACVD did not indicate cumulative tissue response when they were implanted in the muscle and intra-abdominally with direct contact with the viscera. They reduced local tissue reaction (score -2.71 after 56 weeks of the implantation) and internal organ adhesion (irritation score -2.01 and adhesion susceptibility -0.3 after 12 weeks of the implantation) compared with the reference (unmodified by PACVD) knitted implant, which had an identical structure and was made of the same source.
制备了一种经等离子体辅助化学气相沉积(PACVD)单侧改性并具有氟衍生物补充纳米层的针织植入物,用于降低与粘连相关的并发症风险以及术后厚瘢痕的形成。对设计或改性医疗器械的生物学评估是临床前研究的主要方面。如果此类研究使用与结缔组织长时间接触(超过30天)的医疗器械,生物相容性研究需要在体外和体内毒性、致敏性、刺激性和致癌性、生殖和发育毒性方面进行安全性评估。生物学评估的最终方面是生物功能性,以及植入后局部组织反应的评估,从而确定与所使用合成材料的局部生物相容性的所有方面。将经PACVD改性的材料植入肌肉中,使我们能够估计对结缔组织的局部刺激作用,确定瘢痕形成的风险,而将上述针织织物植入腹壁,则有助于评估瘘管形成的风险——主要的术后并发症。该研究旨在评估以纳米结构形式的含氟聚合物经PACVD改性的针织植入物植入后软组织的局部反应。当将未经PACVD改性(对照)和改性的医疗器械植入腹腔(腹内位置)12周或植入肌肉56周时,对设计植入物植入过程中发生的局部效应进行了定量和定性评估。比较性半定量组织学评估包括炎症细胞(多核细胞、淋巴细胞、浆细胞、巨噬细胞、巨细胞)的严重程度和组织反应(坏死、新生血管形成、纤维化和脂肪浸润),采用五点量表进行评估。经PACVD改性的针织植入物在植入肌肉和腹内并与内脏直接接触时,未显示出累积组织反应。与结构相同且来源相同的对照(未经PACVD改性)针织植入物相比,它们降低了局部组织反应(植入56周后评分为-2.71)和内脏粘连(植入12周后刺激评分为-2.01,粘连易感性为-0.3)。